[Federal Register Volume 79, Number 64 (Thursday, April 3, 2014)]
[Notices]
[Pages 18738-18739]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-07484]


=======================================================================
-----------------------------------------------------------------------

REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION

[BAC 416404]


Annual Public Meeting

ACTION: Notice of annual meeting.

-----------------------------------------------------------------------

SUMMARY: The Reagan-Udall Foundation for the Food and Drug 
Administration (FDA), which was created by Title VI of the Food and 
Drug Amendments of 2007, is announcing an annual open public meeting. 
The Foundation will provide an overview of its history, project 
updates, as well as projected activities going forward.

DATES: The open public meeting will be held on May 14, 2014, from 10 
a.m. until 12 p.m. Interested persons may sign up to attend in person 
and/or make comments at the meeting or submit written comments by 
visiting http://www.ReaganUdall.org on or before May 6, 2014. Oral 
comments from the public will be scheduled between approximately 11 
a.m. and 12 p.m. Time allotted for each registrant will be 3 minutes. 
The contact person will notify interested persons regarding their 
request to speak by May 9, 2014. Written comments are encouraged. Those 
individuals interested in making formal comments should notify the 
contact person and submit a brief statement of the general nature of 
the comments they wish to present. Written comments are encouraged 
through May 12, 2014.

ADDRESSES: The public meeting will be held at 901 East Conference 
Center, The Pew Charitable Trusts, 901 East St. NW., Washington, DC 
20004.

FOR FURTHER INFORMATION CONTACT: Jane Reese-Coulbourne, Reagan-Udall 
Foundation for the FDA, 202-828-1206, [email protected].

SUPPLEMENTARY INFORMATION:

I. Background

    The Reagan-Udall Foundation for the FDA (the Foundation) is an 
independent 501(c)(3) not-for-profit organization

[[Page 18739]]

created by Congress to advance the mission of FDA to modernize medical, 
veterinary, food, food ingredient, and cosmetic product development; 
accelerate innovation; and enhance product safety. With the ultimate 
goal of improving public health, the Foundation provides a unique 
opportunity for different sectors (FDA, patient groups, academia, other 
government entities, and industry) to work together in a transparent 
way to create exciting new research projects to advance regulatory 
science.
    The Foundation acts as a neutral third party to establish novel, 
scientific collaborations. Much like any other independently developed 
information, FDA evaluates the scientific information from these 
collaborations to determine how Reagan-Udall Foundation projects can 
help the Agency to fulfill its mission.
    The Foundation's projects include: The Innovation in Medical 
Evidence Development and Surveillance (IMEDS) Program, methods for 
using observational electronic health care data for postmarket evidence 
generation, including postmarket safety surveillance; the Systems 
Toxicology Project, an evaluation of a systems biology approach to 
preclinical safety testing; and the Critical Path to Tuberculosis 
Multidrug Regimens (CPTR) Project, looking at new ways to develop 
tuberculosis combination therapies. The Foundation seeks comments on 
these and other potential topics for future activities.

II. Agenda

    The Foundation will be providing an overview of its history, 
project updates, as well as projected activities going forward. Find 
the Meeting Agenda at http://www.ReaganUdall.org.

    Dated: March 31, 2014.
Jane Reese-Coulbourne,
Executive Director, Reagan-Udall Foundation for the FDA.
[FR Doc. 2014-07484 Filed 4-2-14; 8:45 am]
BILLING CODE 4164-04-P